title: Sticker shock.
abstract: A recent plea by oncologists condemning inflated prices for some cancer drugs has ignited a debate on this topic between clinicians and pharmaceutical companies and highlights the need for a broader assessment of drug valuation.
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics*; D016527:Drug Costs; D004345:Drug Industry; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents